Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial

Carla Casulo,Luca Arcaini,Guillaume Cartron,Koji Izutsu,Armando Santoro,John Radford,Nils Rettby,Jia Ruan,Kiyoshi Ando,Antonello Pinto,Steven Le Gouill,Richard Delarue,Myron S Czuczman ,Marie‐Laure Casadebaig ,Réda Bouabdallah ,Simon Rule,Javier Muñoz ,Brian Fox,Justine Dell’aringa ,Kathryn J Newhall

doi:10.1182/blood-2019-124102

Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial

Carla Casulo, Luca Arcaini + Show 18 more

Open Access

https://doi.org/10.1182/blood-2019-124102

Copy DOI

Journal: Blood	Publication Date: Nov 13, 2019
Citations: 12

Affiliation: University of Rochester Medical Center, University of Pavia, Policlinico San Matteo Fondazione, Istituti di Ricovero e Cura a Carattere Scientifico, University Hospital of Montpellier, Tokyo National Hospital, Humanitas University, Manchester Academic Health Science Centre, University of Manchester, Bristol-Myers Squibb (Switzerland), Cornell University, Tokai University, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Centre Hospitalier Universitaire de Nantes, Institute Paoli-Calmettes, University of Plymouth, The University of Texas MD Anderson Cancer Center

#Speakers Bureau #Diffuse Large B-Cell Lymphoma + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.